A South American company just pumped the first crude out of the Western hemisphere's largest oil discovery in 30 years. Reserves are worth an estimated $560 billion at today's prices! And shares are likely to take off. To get the full details on this stock, and two other explosive companies, go here.
by The Investment U Research Team
Over the past few weeks we’ve seen swine flu, a bankruptcy of Chrysler (not to mention an expected one from GM), a mountain of above-estimate – yet negative – earnings reports, the potential fallout of the commercial real-estate sector, and a pile of economic reports that all point to an economy going nowhere fast.
And yet the markets have marched upwards.
The S&P 500 (.INX) is up almost 30% in just over two months. What’s going on here? We feel like we’re taking crazy pills.
When the markets should have been more optimistic they were pessimistic, when they should have been very afraid they shrugged off the negative data and pushed on.
While its not a shocker that the markets aren’t rational, it does leave us to question if we’re being set up for a perfect storm of “sell in May and go away,” and one more “bottoming out.” We’ve got the ingredients for another serious setback to consumer confidence.
And just like the piano key necktie, no one seems to appreciate it.
For those of you that are just as concerned, you might want to take a look at Rydex 2x Inverse S&P 500 (NYSE: RSW). Or, if you’re feeling negative on financials, energy or health you can speculate specifically in those with Rydex’s sector inverse funds: RFN, REC and RHO.
It’s worth noting that 2x and 3x inverse funds include significant risk – above and beyond simple equities investing. These kinds of investments are not for the risk-adverse or the faint of heart.
Symbols mentioned in this article: .INX, RSW, RFN, REC and RHO.
- Proshares UltraShort Financials (NYSE:SKF): Stock of the Day
- Alphabet Soup Rebound Vs, Ls, Ws, and more?
- Hedge Funds & Private Equity & Bears! Oh My!
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed